Multiple drugsSevere acute respiratory syndrome coronavirus-2 infection, influenza-A virus infection and lack of efficacy: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1815卷 / 1期

关键词：

D O I：

10.1007/s40278-020-81558-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：232 / 232

相关论文

共 50 条

[1] Multiple drugsProlonged severe acute respiratory syndrome coronavirus-2 Omicron variant infection and lack of efficacy : 3 case reports
Reactions Weekly, 2024, 2019 (1) : 334 - 334
[2] ImmunosuppressantsSevere acute respiratory syndrome coronavirus-2 infection: 4 case reports
Reactions Weekly, 2021, 1852 (1) : 230 - 230
[3] ImmunosuppressantsSevere acute respiratory syndrome coronavirus-2 infection and lymphopenia: 2 case reports
Reactions Weekly, 2021, 1859 (1) : 190 - 190
[4] ImmunosuppressantsSevere acute respiratory syndrome coronavirus-2 infection: case report
Reactions Weekly, 2021, 1857 (1) : 174 - 174
[5] FingolimodSevere acute respiratory syndrome coronavirus-2 infection: case report
Reactions Weekly, 2020, 1806 (1) : 135 - 135
[6] OcrelizumabProlonged severe acute respiratory syndrome Coronavirus-2 infection: case report
Reactions Weekly, 2022, 1901 (1) : 388 - 388
[7] Eculizumab/immunosuppressantsSevere acute respiratory syndrome coronavirus-2 infection: case report
Reactions Weekly, 2021, 1861 (1) : 118 - 118
[8] Everolimus/nivolumabSevere acute respiratory syndrome Coronavirus-2 infection: case report
Reactions Weekly, 2021, 1845 (1) : 182 - 182
[9] Multiple drugsSevere acute respiratory syndrome coronavirus 2 infection, renal dysfunction and off label use: case report
Reactions Weekly, 2020, 1833 (1) : 285 - 285
[10] AntineoplasticsSevere acute respiratory syndrome coronavirus 2 infection: 2 case reports
Reactions Weekly, 2020, 1817 (1) : 49 - 49

← 1 2 3 4 5 →